Patel M V, Park J H, Lee S K. "Method for the Synthesis of Gefitinib Impurity 37" [P]. US Patent, US 9240556 B2, 2024-03-03.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质37 in Pharmaceutical Formulations". Chemosphere, 2019, 1999, 6757-6761.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质37 as an Impurity". Anal. Chim. Acta, 2018, 242, (2), 3304-3326.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 37 Using HRMS and NMR". J. Chromatogr. A, 2018, 970, (8), 1008-1012.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 吉非替尼杂质37 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2019, 1076, 6087-6105.